ConforMIS Financials

Based on the key indicators related to ConforMIS's liquidity, profitability, solvency, and operating efficiency, ConforMIS is not in a good financial situation at the moment. It has a very high risk of going through financial straits in April.
  
Understanding current and past ConforMIS Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of ConforMIS's financial statements are interrelated, with each one affecting the others. For example, an increase in ConforMIS's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in ConforMIS's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of ConforMIS. Check ConforMIS's Beneish M Score to see the likelihood of ConforMIS's management manipulating its earnings.

ConforMIS Stock Summary

ConforMIS competes with Bone Biologics, Tivic Health, Bluejay Diagnostics, Vivos Therapeutics, and Rapid Micro. Conformis, Inc., a medical technology company, develops, manufactures, and sells patient-specific products and instrumentation. Conformis, Inc. was incorporated in 2004 and is headquartered in Billerica, Massachusetts. Conformis Inc operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 310 people.
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
ISINUS20717E1010
Business Address600 Technology Park
SectorHealth Care Equipment & Supplies
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitewww.conformis.com
Phone781 345 9001
CurrencyUSD - US Dollar

ConforMIS Key Financial Ratios

ConforMIS Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining ConforMIS's current stock value. Our valuation model uses many indicators to compare ConforMIS value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across ConforMIS competition to find correlations between indicators driving ConforMIS's intrinsic value. More Info.
ConforMIS is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value ConforMIS by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Other Consideration for investing in ConforMIS Stock

If you are still planning to invest in ConforMIS check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ConforMIS's history and understand the potential risks before investing.
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Equity Valuation
Check real value of public entities based on technical and fundamental data
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios